Press Release: Alterome : Alterome Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced that senior management will participate in TD Cowen 45th Annual Health Care Conference and Leerink Partners Global Healthcare Conference 2025. Members of Alterome management will participate in one-on-one investor meetings at both conferences. Details of participation are